These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28743354)

  • 1. Analysis of four serum biomarkers in rheumatoid arthritis: association with extra articular manifestations in patients and arthralgia in relatives.
    Nass FR; Skare TL; Goeldner I; Nisihara R; Messias-Reason IT; Utiyama SRR
    Rev Bras Reumatol Engl Ed; 2017; 57(4):286-293. PubMed ID: 28743354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
    Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
    Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of complement factor B allotypes and serum biomarkers in rheumatoid arthritis patients and their relatives.
    Nass FR; Skare TL; Goeldner I; Nisihara R; Messias-Reason IJ; Utiyama SR
    Int J Immunogenet; 2015 Dec; 42(6):439-44. PubMed ID: 26385602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
    Zengin O; Yıldız H; Demir ZH; Dağ MS; Aydınlı M; Onat AM; Kısacık B
    Adv Clin Exp Med; 2017 Sep; 26(6):987-990. PubMed ID: 29068601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
    Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
    Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
    [No Abstract]   [Full Text] [Related]  

  • 6. Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis.
    Gudowska M; Gindzienska-Sieskiewicz E; Gruszewska E; Cylwik B; Sierakowski S; Szmitkowski M; Chrostek L
    Rev Bras Reumatol Engl Ed; 2017; 57(3):185-189. PubMed ID: 28535888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.
    Ribeiro SL; Pereira HL; Silva NP; Neves RM; Sato EI
    Braz J Med Biol Res; 2008 Nov; 41(11):1005-10. PubMed ID: 19099154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of rheumatoid factor and anti-citrullinated peptide antibodies in relation to rheumatological manifestations in patients with leprosy from Southern Brazil.
    Dionello CF; Rosa Utiyama SR; Radominski SC; Stahlke E; Stinghen ST; de Messias-Reason IJ
    Int J Rheum Dis; 2016 Oct; 19(10):1024-1031. PubMed ID: 26250118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations.
    Wielosz E; Majdan M; Dryglewska M; Zwolak R
    Adv Clin Exp Med; 2018 Sep; 27(9):1253-1257. PubMed ID: 30024658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
    Kamalaksha S; White DHN; Solanki KK
    Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
    Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Detecting Anti-Mutated Citrullinated Vimentin, Anti-Cyclic Citrullinated Peptide, Red Cell Distribution Width and 25-Hydroxyvitamin D in the Diagnosis of Rheumatoid Arthritis.
    Tan L; Gong Y; Zhang Q; Zhang H; Lu X; Huang H
    Lab Med; 2021 Jan; 52(1):80-85. PubMed ID: 32729616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study.
    Alemao E; Guo Z; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME
    Semin Arthritis Rheum; 2018 Apr; 47(5):630-638. PubMed ID: 29241640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
    Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J
    J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new tool for early diagnosis of rheumatoid arthritis using combined biomarkers; synovial MAGE-1 mRNA and serum anti-CCP and RF.
    Aiman AQ; Nesrin M; Amal A; Nassar AD
    Pan Afr Med J; 2020; 36():270. PubMed ID: 33088399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.